Companies: 10,795·Total market cap: $144.5T
AC Immune S.A.

AC Immune S.A.

ACIUNASDAQHealthcare● Active
$2.22
$-0.04(-1.56%)
Market Cap$225428464
P/E Ratio
52W High$4
52W Low$1.65
Overview

AC Immune S.A.(ACIU)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ACIU · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$3.57M$27.31M$14.80M$3.94M$0.00M
Cost of Revenue$0.00M$62.57M$54.61M$0.00M$0.00M
Gross Profit$3.57M($35.26M)($39.80M)$3.94M$0.00M
Gross Margin %(computed)100.00%-129.12%-268.93%100.00%
Operating Expenses
R&D Expenses$56.44M$62.57M$54.61M$60.34M$62.28M
G&A Expenses$11.65M$11.43M$10.58M$9.58M$10.88M
Total Operating Expenses$72.44M$17.12M$13.82M$74.78M$79.01M
Operating Income($68.86M)($52.38M)($53.62M)($70.85M)($79.01M)
Operating Margin %(computed)-191.80%-362.30%
Interest Income$1.86M$3.20M$1.04M$0.07M$6.49M
Interest Expense$0.19M$0.13M$0.18M$0.35M$0.58M
Income Before Tax($70.45M)($50.91M)($54.22M)($70.74M)($72.99M)
Income Tax Expense$0.00M$0.00M$0.01M$0.01M$0.00M
Net Income($70.45M)($50.92M)($54.23M)($70.75M)($73.00M)
Net Margin %(computed)-186.44%-366.41%
Per Share & EBITDA
EPS (Basic)$-0.70$-0.51$-0.64$-0.85$-0.97
Wtd Avg Shares100.75M99.69M84.69M83.55M74.95M
EBITDA($67.75M)($48.62M)($51.83M)($68.03M)($70.01M)
EBITDA Margin %(computed)-178.03%-350.19%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · CHF · M

深入了解AC Immune S.A.

关于AC Immune S.A.(ACIU)损益表

AC Immune S.A.(ACIU)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ACIU实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.07B)(净利率-1971.65%)。

常见问题

ACIU · 4 问

AC Immune S.A.(ACIU)2025财年营收为$0.00B,同比down86.9%。

ACIU revenueACIU salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08